Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution

Metabolism: Clinical and Experimental

Volumn 51, Issue 2, 2002, Pages 260-266

  Meininger, Gary ^a   Hadigan, Colleen ^a   Laposata, Michael ^a   Brown, Joanne ^a   Rabe, Jessica ^a   Louca, Joseph ^a   Aliabadi, Negar ^a   Grinspoon, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FATTY ACID; GLUCOSE; INSULIN; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

ABDOMEN; AGE; AREA UNDER THE CURVE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; LIMB; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; VISCERA;

EID: 0036182863     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.29999     Document Type: Article

References (33)

1. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women
2. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: Relationship to body composition, gonadal function, and protease inhibitor use
3. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
4. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging
5. Clinical factors related to the severity of fat redistribution in the HIV Outpatient Study (HOPS)
6. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
7. A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy
8. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
9. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity
10. Mechanisms of fatty acid-induced inhibition of glucose uptake
11. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM
12. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance
13. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus
14. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin
15. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs
16. Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy
17. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIV-infected patients on highly active antiretroviral therapy (HAART)
18. Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial
19. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
20. Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy
21. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994)
22. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values
23. Plasma free fatty acid concentrations in obesity
24. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia
25. Control of lipolysis and its relevance to development of obesity in man
26. Body fat distribution in healthy young and older men
27. Lipolytic sensitivity to catecholamines in patients with human immunodeficiency virus infection
28. Cross-sectional but not longitudinal associations between non-esterified fatty acid levels and glucose intolerance and other features of the metabolic syndrome
29. Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR)
30. Dysregulation of lipid turnover is a key defect in the HIV lipodystrophy syndrome
31. The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus